Tetrahydrocannabinol - Not For everybody
FDA is dedicated to encouraging the event of cannabis-related drug products, including CBD. FDA encourages researchers to request a Pre-Investigational New Drug software (PIND) meeting to debate questions associated to the event of a specific cannabis-derived and cannabis-related drug product. This ...